CIK: 0001615982 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $593,605 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,699,865 | $78,863 | 13.3% | $19.47 | +18.4% | COM | 92790C104 |
| ACRS | ACLARIS THERAPEUTICS INC | 4,563,962 | $71,882 | 12.1% | $13.57 | +18.5% | COM | 00461U105 |
| AXSM | AXSOME THERAPEUTICS INC | 670,718 | $51,732 | 8.7% | $59.77 | 0.0% | COM | 05464T104 |
| COGT | COGENT BIOSCIENCES INC | 4,038,117 | $46,681 | 7.9% | $7.95 | +55.9% | COM | 19240Q201 |
| TERN | TERNS PHARMACEUTICALS INC | 3,707,891 | $37,746 | 6.4% | $3.72 | +79.1% | COM | 880881107 |
| GHRS | GH RESEARCH PLC | 3,517,125 | $34,186 | 5.8% | $17.34 | -37.6% | ORDINARY SHARES | G3855L106 |
| CELC | CELCUITY INC | 2,105,386 | $29,496 | 5.0% | $10.24 | 0.0% | COM | 15102K100 |
| — | DICE THERAPEUTICS INC | 819,000 | $25,553 | 4.3% | $21.00 | — | COM | 23345J104 |
| — | AEROVATE THERAPEUTICS INC | 747,869 | $21,913 | 3.7% | $16.40 | — | COM | 008064107 |
| PLRX | PLIANT THERAPEUTICS INC | 1,080,000 | $20,876 | 3.5% | $19.13 | +9.3% | COM | 729139105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 2,916,667 | $19,717 | 3.3% | $5.36 | 0.0% | COM | 483497103 |
| NVAX | NOVAVAX INC | 1,879,894 | $19,325 | 3.3% | $17.65 | 0.0% | COM NEW | 670002401 |
| — | MERUS N V | 1,226,214 | $18,970 | 3.2% | $15.47 | — | COM | N5749R100 |
| CABA | CABALETTA BIO INC | 1,895,285 | $17,531 | 3.0% | $3.64 | 0.0% | COM | 12674W109 |
| ANNX | ANNEXON INC | 3,220,050 | $16,648 | 2.8% | $4.00 | +37.4% | COM | 03589W102 |
| — | VECTIVBIO HLDG AG | 1,866,000 | $16,169 | 2.7% | $8.66 | — | ORD SHS | H9060V101 |
| — | PROVENTION BIO INC | 1,118,653 | $11,824 | 2.0% | $7.32 | — | COM | 74374N102 |
| SVRA | SAVARA INC | 6,351,531 | $9,845 | 1.7% | $1.32 | +4.1% | COM | 805111101 |
| MIST | MILESTONE PHARMACEUTICALS IN | 2,208,812 | $8,747 | 1.5% | $7.58 | -30.6% | COM | 59935V107 |
| LIANY | LIANBIO | 4,793,047 | $7,861 | 1.3% | $6.16 | — | SPONSORED ADS | 53000N108 |
| — | MARINUS PHARMACEUTICALS INC | 1,770,705 | $7,047 | 1.2% | $11.98 | — | COM NEW | 56854Q200 |
| TRVI | TREVI THERAPEUTICS INC | 3,050,022 | $5,887 | 1.0% | $2.46 | -19.8% | COM | 89532M101 |
| FULC | FULCRUM THERAPEUTICS INC | 447,326 | $3,257 | 0.5% | $7.16 | -8.9% | COM | 359616109 |
| — | LYRA THERAPEUTICS INC | 924,170 | $2,902 | 0.5% | $5.65 | — | COM | 55234L105 |
| — | INOZYME PHARMA INC | 2,709,987 | $2,845 | 0.5% | $4.77 | — | COM | 45790W108 |
| ATYR | ATYR PHARMA INC | 1,171,436 | $2,565 | 0.4% | $5.98 | -60.6% | COM NEW | 002120202 |
| — | AFFIMED N V | 1,428,571 | $1,771 | 0.3% | $5.52 | — | COM | N01045108 |
| — | RALLYBIO CORP | 268,532 | $1,764 | 0.3% | $7.55 | — | COM | 75120L100 |